Clinical Laserthermia Systems AB (publ) (STO:CLS.B)

Market Cap	74.75M
Revenue (ttm)	18.78M
Net Income (ttm)	-47.62M
Shares Out	25.34M
EPS (ttm)	-4.33
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,943
Average Volume	73,825
Open	2.885
Previous Close	2.950
Day's Range	2.885 - 3.025
52-Week Range	2.430 - 23.500
Beta	0.20
RSI	52.35
Earnings Date	May 16, 2025

About STO:CLS.B

Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment. In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices. Clinical Laserther...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 17
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: CLS.B

Financial Performance

In 2024, STO:CLS.B's revenue was 18.78 million, an increase of 127.04% compared to the previous year's 8.27 million. Losses were -47.62 million, -40.32% less than in 2023.